FAQ

UNBS 1450

Known as: UNBS-1450, UNBS1450 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
012320062017

Related topics

Related topics

1 relation

Broader (1)

Cardenolides

Related mentions per year

Related mentions per year

1958-2018
1960198020002020
UNBS 1450
Cardenolides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma
A limiting factor in the therapeutic outcome of children with high-risk neuroblastoma is the intrinsic and acquired resistance to… (More)
  • figure 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells.
Cardiac steroids are used to treat various diseases including congestive heart failure and cancer. The aim of this study was to… (More)
Is this relevant?
2011
2011
Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth.
Recent studies revealed the potential of Na(+)/K(+)-ATPase as a target for anticancer therapy and showed additional modes of… (More)
Is this relevant?
2009
2009
The sodium pump α1 sub-unit: a disease progression–related target for metastatic melanoma treatment
Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.
OBJECTIVE Ion transporters play pivotal roles in cancer cell migration in general and in glioblastomas (GBMs) in particular… (More)
Is this relevant?
2008
2008
Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity.
The use of cardenolides like ouabain, digitoxin, or oleandrin has been reported previously many times as a means of potentially… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.
With an overall 5 year survival rate as low as 15% for non-small cell lung cancer (NSCLC), even with surgical intervention and… (More)
Is this relevant?
2006
2006
Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.
Non-small cell lung cancers (NSCLCs) are the leading cause of cancer deaths in most developed countries. Targeting heat shock… (More)
Is this relevant?
2006
2006
The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells.
Non-small cell lung cancers (NSCLC) are associated with very dismal prognoses, and adjuvant chemotherapy, including irinotecan… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
The cardenolide UNBS1450 is able to deactivate nuclear factor KB–mediated cytoprotective effects in human non–small cell lung cancer cells
Non–small cell lung cancers (NSCLC) are associated with very dismal prognoses, and adjuvant chemotherapy, including irinotecan… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?